HCC827(人非小细胞肺癌细胞)

https://789.bio/ec/984x14
  • https://789.bio/ec/984x14
  • https://789.bio/ec/K0G0R0
  • https://789.bio/ec/hiLChS
  • https://789.bio/ec/hayuH4
  • https://789.bio/ec/Z5RC8G
  • https://789.bio/ec/H4tH8O
  • https://789.bio/ec/yyeWD0

货号: CL-0094

Price: ¥1600 ¥1600

Size:
1×10^6Cells/T25 1×10^6Cells/Vial×2Vials

生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]

产品信息

产品名称 HCC827(人非小细胞肺癌细胞)
别称 HCC-827; HCC0827
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40% FBS+5% DMSO
温度:液氮
培养方案A(默认) 生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]
培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃
培养方案B(可选) 生长培养基:
培养条件: 气相:, 温度:37℃
推荐传代比例 1:3-1:4
推荐换液频率 2-3次/周

参考资料(来源文献)

背景描述 HCC827细胞是于1994年3月建系,组织提供者在25岁到26岁时每个月抽1包烟,在诊断前12年不再抽烟。HCC827细胞在EGFR酪氨酸激酶区域有一个获得性突变(E746-A750缺失)。
年龄(性别) 39Y Female
组织来源 肺腺癌
细胞类型 肿瘤细胞
肿瘤类型 肺癌细胞
生物安全等级 BSL-1

STR位点信息

STR鉴定图

  • Molecular Stratification and Treatment Monitoring of Lung Cancer Using a Small Extracellular Vesicle-Activated Nanocavity Architecture(2024)

    作者:Junrong Li, Meiqin Li, Alain Wuethrich, Rui Guan, Lihui Zhao, Cong Hu, Matt Trau, Yao Sun

    期刊:ANALYTICAL CHEMISTRY

    DOI:10.1021/acs.analchem.4c00558

    影响因子:6.7

    引用产品: A549 [A-549] 细胞, HCC827 细胞, NCI-H1299 细胞, BEAS-2B 细胞

  • Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma(2024)

    作者:Wu Sixuan, Pan Junfan, Pan Qihong, Zeng Lijun, Liang Renji, Li Yuehua

    期刊:Frontiers in Immunology

    DOI:10.3389/fimmu.2024.1453220

    影响因子:5.7

    引用产品: BEAS-2B 细胞, NCI-H1299 细胞, PC-9 细胞, HCC827 细胞, A549 [A-549] 细胞

  • CALU promotes lung adenocarcinoma progression by enhancing cell proliferation, migration and invasion(2024)

    作者:Li Yan, Sun Shengnan, Zhang Hui, Jing Yongjian, Ji Xingzhao, Wan Qiang, Liu Yi

    期刊:RESPIRATORY RESEARCH

    DOI:10.1186/s12931-024-02901-3

    影响因子:4.7

    引用产品: NCI-H1299 细胞, HCC827 细胞, PC-9 细胞, 95-D [PLA-801D] 细胞, A549 [A-549] 细胞, Hela 299 细胞, NCI-H1975 细胞

  • Synergistic antitumor activity of baicalein combined with almonertinib in almonertinib-resistant non-small cell lung cancer cells through the reactive oxygen species-mediated PI3K/Akt pathway(2024)

    作者:Chen Teng, Zhang Pei, Cong Xiao-Fan, Wang Yuan-Yuan, Li Shuo, Wang Hao, Zhao Su-Rong, Sun Xiao-Jin

    期刊:Frontiers in Pharmacology

    DOI:10.3389/fphar.2024.1405521

    影响因子:4.4

    引用产品: NCI-H1975 细胞, HCC827 细胞

  • LINC00941 is a diagnostic biomarker for lung adenocarcinoma and promotes tumorigenesis through cell autophagy(2024)

    作者:Qin Yang, Xi Yong, Xiaoli Chen, Rong Huang, Xiaolin Wang, Zhengmin Xu, Wei Chen

    期刊:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

    DOI:10.1111/jcmm.70076

    影响因子:4.3

    引用产品: NCI-H1299 细胞, NCI-H1975 细胞, Ham's F-12K 培养基, HCC827 细胞, A549 [A-549] 细胞

  • Experimental study on the inhibitory effect of Halofuginone on NSCLC(2024)

    作者:Yuehua Han, Shiyao Liu, Juan Zhu, Peipei Liu, Zixuan Meng, Yongping Li, Shanshan Li, Fangtian Fan, Mengxiao Zhang, Hao Liu

    期刊:EUROPEAN JOURNAL OF PHARMACOLOGY

    DOI:10.1016/j.ejphar.2024.177221

    影响因子:4.2

    引用产品: HCC827 细胞, NCI-H1975 细胞

  • The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer(2024)

    作者:Tao Honglei, Li Lei, Li Huiling, Ma Tingting, Zhu Xinping, Cao Jili, Zhu Yongqiang, Zhu Shengmei, Li Mingqian

    期刊:Scientific Reports

    DOI:10.1038/s41598-024-81912-y

    影响因子:3.8

    引用产品: NCI-H1299 细胞, HCC827 细胞, Annexin V Binding Buffer (10×)

  • Cytochalasin H enhances sensitivity to gefitinib in non-small-cell lung cancer cells through inhibiting EGFR activation and PD-L1 expression(2024)

    作者:Zhang Guihong, Liu Jiao, Li Sanzhong, Wang Tianyu, Chen Li, Li Huan, Ding Qingkai, Li Xiangyong, Zhu Shaoping, Tang Xudong

    期刊:Scientific Reports

    DOI:10.1038/s41598-024-76060-2

    影响因子:3.8

    引用产品: NCI-H1975 细胞, HCC827 细胞

  • CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway(2024)

    作者:Yunlian Diao, Shibo Huang, Fangpeng Liu, Shu Liao, Chenxi Guan, Xiaojian Xiong, Ping Zhang, Junyao Li, Wei Zhang, Ying Ying

    期刊:ACTA BIOCHIMICA ET BIOPHYSICA SINICA

    DOI:10.3724/abbs.2024106

    影响因子:3.3

    引用产品: HCC827 细胞, RPMI-1640 培养基, 特级胎牛血清

  • Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction(2024)

    作者:Feng Zhang, Qimeng Yu, Caiyun Wu, Shishi Sun, Yu Wang, Rui Wang, Zejie Chen, Hua Zhang, Xuqiong Xiong, Annoor Awadasseid, Guowu Rao, Xiaoyin Zhao, Wen Zhang

    期刊:BIOORGANIC & MEDICINAL CHEMISTRY

    DOI:10.1016/j.bmc.2024.117867

    影响因子:3.3

    引用产品: HCC827 细胞

  • Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?

    部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图

联系我们

400-999-2100

24小时服务热线

sales@procell.com.cn

销售邮箱

×
微信客服 联系我们 返回顶部
在线咨询